Literature DB >> 2694154

Exophthalmus--prenatal ultrasonic features for diagnosis of Crouzon syndrome.

Y Menashe1, G Ben Baruch, O Rabinovitch, Y Shalev, M B Katzenlson, E Shalev.   

Abstract

Prenatal real-time ultrasonographic diagnosis of exophthalmus is presented. Diagnosis was made at the 35th week of gestation in a fetus of a patient affected with Crouzon syndrome (craniofacial dysotosis). Recognition of exophthalmus as a part of Crouzon syndrome and the easy visualization of the eye balls and palpebrae in the third trimester made the diagnosis possible.

Entities:  

Mesh:

Year:  1989        PMID: 2694154     DOI: 10.1002/pd.1970091109

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  5 in total

1.  Jackson-Weiss syndrome registered in four successive generations. The facies of Crouzon's syndrome with foot abnormalities.

Authors:  B Stanković; V Krstić; B Stankov; L Jojić; M Nagulić; G Artiko
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

Review 2.  Revisiting Crouzon syndrome: reviewing the background and management of a multifaceted disease.

Authors:  Samuel N Helman; Arvind Badhey; Sameep Kadakia; Eugene Myers
Journal:  Oral Maxillofac Surg       Date:  2014-09-24

3.  An inherited FGFR2 mutation increased osteogenesis gene expression and result in Crouzon syndrome.

Authors:  Jiayan Fan; Yinwei Li; Renbing Jia; Xianqun Fan
Journal:  BMC Med Genet       Date:  2018-05-30       Impact factor: 2.103

4.  Detection of G338R FGFR2 mutation in a Vietnamese patient with Crouzon syndrome.

Authors:  Anh Lan Thi Luong; Thuong Thi Ho; Ha Hoang; Trung Quang Nguyen; Tu Cam Ho; Phan Duc Tran; Thuy Thi Hoang; Nam Trung Nguyen; Hoang Ha Chu
Journal:  Biomed Rep       Date:  2019-01-03

5.  Inherited FGFR2 mutation in a Chinese patient with Crouzon syndrome and luxation of bulbus oculi provoked by trauma: a case report.

Authors:  Ji Yang; Tao Tao; Hai Liu; Zhu-Lin Hu
Journal:  BMC Ophthalmol       Date:  2019-10-22       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.